KNG1 and cardiovascular disorder: This is particularly relevant in view of the recent evidence from preclinical and clinical studies with bradykinin type 2 receptor inhibitors, which has shown that BK contributes to the pathogenesis of diseases of the cardiovascular system and of inflammatory diseases that lead to pain.